API | macrogol

macrogol Report issue

Small molecule Experimental

AACT ChEMBL DrugBank Drug Central PubChem

Active Ingredient History

NOW

Macrogol, also known as polyethylene glycol (PEG), is used as a medication to treat constipation in children and adults. It is also used to empty the bowels before a colonoscopy. It is taken by mouth. Benefits usually occur within three days. Generally it is only recommended for up to two weeks. It is also used as an excipient. ^Wikipedia

Chemistry

SMILES: OCCO
InChIKey: LYCAIKOWRPUZTN-UHFFFAOYSA-N
Mol. Mass: 62.07
ALogP: -1.03 Partition coefficient
ChEMBL Molecules:

polyethylene glycol

macrogol

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

1,2-ethanediol | atpeg 300 | carbowax sentry | ethylene glycol | macrogol

Organizations (17)

Research & Development (17)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (8)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (8)

Adenomatous Polyps (Phase 2)

Cathartics (Phase 4)

Colonoscopy (Phase 4)

Colorectal Neoplasms (Phase 4)

Constipation (Phase 4)

Diagnosis (Phase 3)

Intestine, Large (Phase 3)

Liver Diseases (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 17
# of Trial Organizations: 17

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue